Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 07 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Quant Large & Mid Cap Fund |
|---|---|
| 07 Jan 2013 | ₹100.00 |
| 25 Feb 2014 | ₹93.01 |
| 16 Apr 2015 | ₹138.39 |
| 03 Jun 2016 | ₹149.82 |
| 23 Jul 2017 | ₹169.80 |
| 10 Sep 2018 | ₹159.02 |
| 30 Oct 2019 | ₹163.61 |
| 17 Dec 2020 | ₹201.22 |
| 04 Feb 2022 | ₹297.95 |
| 26 Mar 2023 | ₹296.01 |
| 13 May 2024 | ₹519.80 |
| 02 Jul 2025 | ₹536.38 |
| 20 Aug 2026 | ₹578.18 |
| Metric | quant · Direct · IDCW NAV ₹64.87 Very High risk ★★★★☆ | Category median Large & Mid Cap Fund · 35 funds |
|---|---|---|
| +12.25% | +4.31% | |
| +17.25% | +12.18% | |
| +18.16% | +12.13% | |
| +13.99% | +9.85% | |
| +13.76% | +11.44% | |
| +15.37% | — | |
| +15.59% | +13.24% | |
| +14.67% | +12.72% | |
| +14.79% | +11.19% | |
| Risk | ||
| 16.54% | 15.59% | |
| 0.65 | 0.20 | |
| 0.89 | 0.26 | |
| -36.46% | -38.41% | |
| Nifty Midcap 150 | — | |
| +0.23% | -3.79% | |
| 1.01 | 0.85 | |
| 94.3% | 81.7% | |
| 88.8% | 93.5% | |
| 1.25% | 1.06% | |
| ₹3,496Cr | ₹3,576Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 0% | 40% | |
| Sanjeev Sharma | — | |
| 07 Jan 2013 | — | |
| 20 | — | |
| 64.0% | — | |
| 3.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.